|
Decorated Veteran and FBI Analyst Sues FBI after
Falsely Being Accused of Disloyalty to the United States
This week, we filed a lawsuit on behalf of FBI analyst Marcus Allen in the
U.S. District Court for the District of South Carolina against FBI Director
Christopher Wray for violating Allen’s constitutional rights by falsely
accusing him of holding “conspiratorial views,” stripping his security
clearance, and suspending him from duty without pay (Marcus O. Allen v
Christopher Wray (No. 22-cv-4536)).
The FBI revoked his security clearance because apparently, the FBI believes
that any views contrary to its own regarding what occurred on January 6
constitutes disloyalty to the United States.
The new lawsuit details Allen’s outstanding military and FBI service:
Because of his outstanding military service, [Allen] was awarded the
Navy and Marine Corps Commendation Medal and the Navy and Marine Corps
Achievement Medal. In 2004, [Allen] was designated the Marine Corps
Intelligence Activity Runner-Up for Intelligence NCO of the year.
***
In 2015, [Allen] joined the FBI as a staff operations specialist. Among
other tasks, he has provided ad hoc all-source analytical support to the
FBI Charlotte Field Office Joint Terrorism Task Force. He has consistently
been rated “Exceeds Fully Successful” on his FBI performance
evaluations. He received the FBI Charlotte Field Office Employee of the
Year Award in 2019.
[Allen] first received a Top Secret security
clearance in early 2001.
Despite Allen’s exemplary service, in a January 10, 2022, letter the FBI
asserted:
The Security Division has learned you have espoused conspiratorial views
both orally and in writing and promoted unreliable information which
indicates support for the events of January 6th. These allegations raise
sufficient concerns about your allegiance to the United States and your
judgment to warrant a suspension of your clearance pending further
investigation.
In a February 17, 2022, letter the FBI further notified Allen that he was
being placed on administrative leave without pay due to the suspension of
his security clearance.
The lawsuit states:
[Allen’s] allegiance is to the United States, as he has demonstrated
during his years of exemplary military and law enforcement service to his
country.
[Allen] was not involved in the events of
January 6 and did not support them in any material way. The FBI has
made no allegation or offered any evidence to the contrary.
[Allen] has expressed no view that could be
reasonably interpreted as personally expressing support or sympathy for any
unlawful activity that occurred on January 6.
The FBI has not identified any specific
statements or actions supporting its contention that Plaintiff has done
otherwise.
We contend that the FBI did not give Allen a chance to clear himself,
despite his repeated inquiries. In early May 2022, however, the FBI
requested that Allen appear for an interview. He promptly complied. The
interview request came only days after FBI Director Wray was confronted by
members of Congress over concerns that the FBI was weaponizing the security
clearance process to target politically conservative employees. Since that
time, Allen has received no further word on the status of the FBI’s
investigation.
On June 7, 2022, Rep. Jim Jordan, ranking member of the House Judiciary
Committee, sent a letter to Wray
regarding the firing of FBI employees, noting that, “Multiple
whistleblowers have called it a ‘purge’ of FBI employees holding
conservative views.”
The lawsuit alleges several violations of Allen’s First and Fifth
Amendment rights and asks that Allen’s security clearance and employment
be restored.
The FBI can’t purge employees based on political smears. We are reminding
the FBI that it is not above the law with this civil rights lawsuit for Mr.
Allen, a decorated Marine veteran and highly regarded FBI employee.
FDA Records: Significant Number of mRNA Test Rats Born with Skeletal
Deformations
We continue to investigate the government’s approval of the COVID
vaccines.
Most recently, we received 699 pages of records
from the Department of Health and Human Services regarding data Moderna
submitted to the FDA on its mRNA COVID-19 vaccine, which indicate a
“statistically significant” number of rats were born with skeletal
deformations after their mothers were injected with the vaccine.
The documents also reveal Moderna elected not to conduct a number of
standard pharmacological studies on the laboratory test animals.
We obtained the records through a September 2021 FOIA lawsuit we filed after
the FDA, the Centers for Disease Control and Prevention and the National
Institute for Allergy and Infectious Disease (NIAID) failed to respond to a
June 2021 FOIA request biodistribution studies and related data for the
Pfizer, Moderna and Johnson & Johnson COVID vaccines (Judicial Watch v. U.S.
Department of Health and Human Services (No.
1:21-cv-02418)).
These previously hidden records about the COVID-19 vaccine safety and
efficacy studies raise a number of disturbing questions. The fact that it
has taken a federal lawsuit to get access to this material is yet another
scandal.
The records include a “Nonclinical
Overview” prepared by Moderna and submitted to the FDA for approval
of its vaccine revealing that a number of rats were born with skeletal
deformations, known as “wavy ribs” and “rib nodules,” to mothers
injected with the mRNA vaccine. The study dismissed the anomalies as “not
considered adverse:”
mRNA-1273-related variations in skeletal examination included
statistically significant increases in the number of F1 rats with 1 or more
wavy ribs and 1 or more rib nodules. Wavy ribs appeared in 6 fetuses and 4
litters with a fetal prevalence of 4.03% and a
litter prevalence of 18.2%. Rib nodules appeared in 5 of those 6 fetuses.
Skeletal variations are structural changes that do not impact development
or function of a developing embryo, are considered reversible, and often
correlate with maternal toxicity and/or lack of other indicators of
developmental toxicity (Carney and Kimmel 2007). Maternal toxicity in the
form of clinical observations was observed for 5 days following the last
dose (GD 13), correlating with the most sensitive period for rib
development in rats (GDs 14 to 17). Furthermore, there were no other
indicators of mRNA-1273-related developmental toxicity observed, including
delayed ossification; therefore, these common skeletal variations were not
considered adverse.
(Non-adverse deformations receive a different perspective in the July 2009
Environmental Research article, “Dose–response
relationships of rat fetal skeleton variations: Relevance for risk
assessment:”
(Whether or not a substance-induced increase in the incidence of fetal
skeleton variations should be taken into account for human risk assessment
is a long-standing controversial issue. It has been argued that
chemical-produced increases in variations are not to be considered for risk
assessment because they are “unlikely to adversely affect survival or
health.” The counter argument is that even not being overtly adverse and
conveying no apparent selective disadvantage, a treatment-induced increase
in the occurrence of variations means that the chemical agent has the
potential to perturb skeleton development. According to this view, under a
different condition of exposure, or in another species, this perturbation
of normal bone formation may give rise to a different and more severe
outcome.))
A “Pharmacokinetics Written
Summary” marked “Confidential,” indicates that the information it
contains is related to the mRNA-1273 (Moderna vaccine) strain; however,
much of the data comes from work with mRNA-1647. The study states:
The results of a biodistribution study of mRNA-1647 support the
development of mRNA-1273.
***
The biodistribution of mRNA-1647 was evaluated in a non-Good Laboratory
Practice (GLP), single-dose, intramuscular (IM) injection study in Sprague
Dawley rats…. mRNAs that are within an LNP of the same composition (e.g.,
mRNA-1273 and mRNA-1647) are expected to distribute similarly.
mRNA-1273 is Moderna’s covid vaccine, which was delivered to the
National Institutes of Health in February 2020 for study. mRNA-1647 is a
previously developed vaccine for the cytomegalovirus.
The “Summary” indicates:
- No absorption studies with mRNA-1273 [used in Moderna’s COVID
vaccine] have been performed.
- No metabolism studies with mRNA-1273 have been performed.
- No excretion studies with mRNA-1273 have been performed.
- No PK [pharmacokinetic]
studies with mRNA-1273 have been performed.
- No other PK studies with mRNA-1273 have been performed.
(According to PubMed.gov,
“Pharmacokinetics studies are performed to clarify the absorption,
distribution, metabolism, and excretion of drug candidates…[and] are
required for establishing the efficacy and safety in humans.”)
A separate study submitted to the
FDA sponsored by Moderna Therapeutics Inc. and conducted by Charles River
Laboratories in Montreal, Canada, is titled “A Single Dose Intramuscular
Injection Tissue Distribution Study of mRNA-1647 in Male Sprague-Dawley
Rats” in which “[t]he objective … was to determine the tissue
distribution of mRNA-1647,” as opposed to mRNA-1273 used in Moderna’s COVID
vaccine.
In one appendix to the study, a “clarification” was issued in the
toxicokinetic report regarding the half-life of mRNA injected into the
rats, noting: “The average value of terminal half-life for the muscle
(i.e. injection site) in Sections 4.2 and 5 of the toxicokinetic report
should be read 14.9 [hours] instead of 8.39 [hours] based on the results of
the toxicokinetic evaluation.”
The study further notes that the wording of the conclusion was modified to
read, “The half-life … of mRNA-1647 was reliably estimated in muscle
(site of injection), proximal popliteal and axillary distal lymph nodes,
and spleen with average values for all construct t½ [half-life] of
14.9 8.39, 34.8, 31.1 and 63.0 hours, respectively.”
[Emphasis in original]
Another appendix, titled “Summary Mean (±SE) mRNA-1647 Pharmacokinetic
Parameters in Sprague-Dawley Rat in Plasma and Tissues Following 100μg
Intramuscular Injection Administration of mRNA-1647 on Day 1,” reveals
that, in addition to distributing to the muscle site, lymph nodes and
spleen, the mRNA particles also distributed to the bone marrow, brain,
eyes, heart, liver, lungs, stomach and testes.
A separate study indicates that
the mRNA-1647 particles injected into rats were “observed in muscle (i.e. site of injection), followed by proximal
(popliteal) lymph nodes, axillary lymph nodes and spleen, suggesting the
mRNA-1647 distribution to the circulation by lymph flow.” (The mRNA was
delivered via “lipid nanoparticle dispersion.”)
Through FOIA we have uncovered a substantial amount of information
regarding COVID-19 issues:
- In October 2020, we received FDA records that detailed pressure for COVID-19
vaccine booster approval and use.
- NIH records revealed an FBI
“inquiry” into the NIH’s controversial bat coronavirus grant tied to
the Wuhan Institute of Virology. The records also show National Institute
of Allergy and Infectious Diseases (NIAID) officials were concerned about
“gain-of-function” research in China’s Wuhan Institute of Virology in
2016. The Fauci agency was also concerned about EcoHealth Alliance’s
lack of compliance with reporting rules and use of gain-of-function
research in the NIH-funded research involving bat coronaviruses in Wuhan,
China.
- HHS records revealed that from 2014 to 2019, $826,277 was given to
the Wuhan Institute of Virology for bat coronavirus research by the
NIAID.
- NIAID records showed that it gave nine China-related
grants to EcoHealth Alliance to research coronavirus emergence in bats
and was the NIH’s top issuer of grants to the Wuhan lab itself. The
records also included an email from the vice director of the Wuhan Lab
asking an NIH official for help finding disinfectants for decontamination
of airtight suits and indoor surfaces.
- HHS records included an “urgent for Dr. Fauci
” email chain, citing ties between the Wuhan lab and the taxpayer-funded EcoHealth Alliance.
The government emails also reported that the foundation of U.S. billionaire
Bill Gates worked closely with the Chinese government to pave the way for
Chinese-produced medications to be sold outside China and help “raise
China’s voice of governance by placing representatives from China on
important international counsels as high level commitment from
China.”
- HHS records included a grant application for research involving the
coronavirus that appears to describe “gain-of-function”
research involving RNA extractions from bats, experiments on viruses,
attempts to develop a chimeric virus and efforts to genetically manipulate
the full-length bat SARSr-CoV WIV1 strain molecular clone.
- HHS records showed the State Department and NIAID knew immediately in
January 2020 that China was withholding
COVID data, which was hindering risk assessment and response by public
health officials.
- University of Texas Medical Branch (UTMB) records show the
former director of the Galveston National Laboratory at the University of
Texas Medical Branch (UTMB), Dr. James W. Le Duc
warned Chinese researchers at the Wuhan Institute of Virology of potential
investigations into the COVID issue by Congress.
- HHS records regarding biodistribution studies and related data for the
COVID-19 vaccines show a key component of the vaccines developed by
Pfizer/BioNTech, lipid nanoparticles (LNPs), were found outside the injection
site, mainly the liver, adrenal glands, spleen and ovaries of test
animals, eight to 48 hours after injection.
- Records from the Federal Select Agent Program (FSAP) reveal safety lapses and
violations at U.S. biosafety laboratories that conduct research on
dangerous agents and toxins.
- HHS records include emails between
National Institutes of Health (NIH) then-Director Francis Collins and
Anthony Fauci, the director of National Institute of Allergy and Infectious
Diseases (NIAID), about hydroxychloroquine and COVID-19.
- HHS records show that NIH officials tailored confidentiality
forms to China’s terms and that the World Health Organization (WHO)
conducted an unreleased, “strictly confidential” COVID-19
epidemiological analysis in January 2020.
- Fauci emails include his
approval of a press release supportive of China’s response to the 2019
novel coronavirus.
Driver’s License Security Law Delayed Another Two Years over
COVID
The Biden administration is not in a hurry to enact a commonsense safeguard,
adopted after the 9/11 attack in 2001, to protect against the misuse of
driver’s licenses by terrorists. Two decades later, we’re still
waiting, as our Corruption Chronicles blog reports.
More than two decades after the worst terrorist attack on U.S. soil, the
Biden administration is using COVID-19 as an excuse to further delay
enforcement of a law requiring minimum security standards for driver’s
licenses and identification cards. The measure, known as the REAL ID Act, was
passed by Congress after 9/11 to establish a more secure national system
less prone to fraud after several of the hijackers exploited loopholes to
obtain dozens of driver’s licenses from various states. The cards allowed
them to take flight lessons and board planes to carry out the 2001 attacks.
At the recommendation of the 9/11 Commission
Congress passed the law in 2005 and states originally had until 2011 to
comply, though the Obama administration tried to drastically weaken the
legislation. Obama Homeland Security Secretary Janet Napolitano granted a
20-month extension on the deadline as she worked behind the scenes to undermine the REAL ID
Act, asserting that it violates civil liberties and privacy.
In the fall of 2020 the Department of
Homeland Security (DHS) announced that, after
multiple delays, all 50 states were finally in full compliance with the
REAL ID Act with most states becoming compliant under pressure from the
Trump administration. “To date, the 50 states have issued more than 105
million REAL ID-compliant driver’s licenses and identification cards,
representing 38 percent of all driver’s licenses and identification card
holders,” DHS revealed at the time. In less than a year full enforcement
of REAL ID will take effect at all federally regulated airports, federal
facilities, and nuclear power plants, the 2020 bulletin further states.
That means federal agencies, such as the Transportation Security
Administration (TSA), will be prohibited from accepting licenses and ID
cards that do not meet the law’s standards. Though it was welcome news at
the time, it was still outrageous that it took 15 years after Congress
passed the legislation to protect national security.
This month, the Biden administration is
extending REAL ID full enforcement for another two years to give states
more time to ensure residents have driver’s licenses and identification
cards that meet the law’s security standards. “The extension is
necessary, in part, to address the lingering impacts of the COVID-19
pandemic on the ability to obtain a REAL ID driver’s license or
identification card,” according to a DHS notice issued last week. The
pandemic hindered REAL ID progress, the agency writes, because state
driver’s licensing agencies had to work through backlogs and many
automatically extended license expiration dates and shifted operations to
appointment only. Keep in mind the agencies had more than enough time to
comply before COVID. Rest assured however, DHS continues to work closely
with states to finally meet REAL ID requirements, according to Secretary
Alejandro Mayorkas. “We will continue to ensure that the American public
can travel safely,” Mayorkas said.
The continued delays are inexcusable
considering what is at stake. The measure’s crucial verification process
requires states to certify the authenticity of every driver’s license
applicant by requiring that documents, such as a birth certificate or
passport, be submitted to get the card are legitimate and that the
applicant is in the United States legally. It also calls for a newly
created federal database to link all licensing information that must be
checked before states issue new cards. This will establish a much-needed
standardized national driver’s license system less vulnerable to fraud
and will prevent terrorists from abusing it as did September 11 hijackers.
Once the law is fully enforced, federal agencies will be prohibited from
accepting driver’s licenses or ID cards from noncompliant states for
official purposes, including boarding an aircraft, accessing a federal
facility, and entering a nuclear power plant.
It is not clear how the Biden administration
plans to handle the dozen states—including Arkansas, California, Maine,
and Oregon as well as the District of Columbia—that offer gender-neutral
licenses and ID cards in violation of the REAL ID Act. Title II of the act
specifically states that “features on each driver’s license and
identification card issued to a person by the State” must include: The
person’s full legal name; the person’s date of birth; the person’s
gender; the person’s driver’s license or identification card number; a
digital photograph of the person; the person’s address of principle
residence; the person’s signature; physical security features designed to
prevent tampering, counterfeiting or duplication of the document for
fraudulent purposes; a common machine-readable technology with defined
minimum data elements.
Until next week,
|
|
|
|
|
|
|
|
|
Judicial Watch, Inc.
425 3rd St Sw Ste 800
Washington, DC 20024
|
|
202.646.5172 |
|
|
© 2017 - 2022, All Rights Reserved
Manage
Email Subscriptions |
Unsubscribe |
|
|
|
|
|
|
|
|